1.Periocular Tinea Caused by Trichophyton rubrum.
Myung Hoon LEE ; Ji Young YOO ; You Bum SONG ; Moo Kyu SUH ; Gyoung Yim HA ; Jung Ran KIM ; Jong Soo CHOI
Korean Journal of Dermatology 2013;51(12):997-998
No abstract available.
Eyelids
;
Tinea*
;
Trichophyton*
2.Validity and Reliability of the Person-centered Care Assessment Tool in Long-term Care Facilities in Korea.
Young Ran TAK ; Hae Young WOO ; Sun Young YOU ; Ji Hye KIM
Journal of Korean Academy of Nursing 2015;45(3):412-419
PURPOSE: The aim of this study was to evaluate the validity and reliability of the Korean version of the Person-centered Care Assessment Tool (P-CAT). METHODS: The English P-CAT was translated into Korean with forward and backward translation. Survey data were collected from 458 staff in 17 long-term care facilities in Korea. Construct validity and criterion related validity were evaluated. Cronbach's alpha was used to assess reliability. RESULTS: The Korean version of P-CAT was shown to be valid homogeneously by factor, item and content analysis. Internal consistency reliability was satisfactory in which the values of factor 1, factor 2 and the total scale were .84, .77 and .86 respectively. Exploratory factor analysis supported the construct validity with a two-factor solution. Factor loadings of the 13 items ranged in .34~.80. Criterion validity to the Person-centered Climate Questionnaire-staff (PCQ-S) was .74 (p<.001). CONCLUSION: The Korean version of the P-CAT was found to be an applicable instrument with satisfactory reliability and validity for further use in measuring successful person-centered care in long-term care facilities for older persons.
Adult
;
Female
;
Humans
;
*Long-Term Care
;
Male
;
Middle Aged
;
Nursing Staff, Hospital/*psychology
;
*Program Evaluation
;
Reproducibility of Results
;
Republic of Korea
;
Surveys and Questionnaires
;
Translating
3.Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation.
Min Jae LEE ; Soon Shin CHO ; Hyung Suk JANG ; Young Shin LIM ; Ji Ran YOU ; Jang Won PARK ; Hea Ran SUH ; Jeong A KIM ; Jong Sang PARK ; Duk Kyung KIM
Experimental & Molecular Medicine 2002;34(4):265-272
In vivo electroporation has emerged as a leading technology for developing nonviral gene therapies, and the various technical parameters governing electroporation efficiency have been optimized by both theoretical and experimental analysis. However, most electroporation parameters focused on the electric conditions and the preferred vehicle for plasmid DNA injections has been normal saline. We hypothesized that salts in vehicle for plasmid DNA must affect the efficiency of DNA transfer because cations would alter ionic atmosphere, ionic strength, and conductivity of their medium. Here, we show that half saline (71 mM) is an optimal vehicle for in vivo electroporation of naked DNA in skeletal muscle. With various salt concentrations, two reporter genes, luciferase and beta-galactosidase were injected intramuscularly under our optimal electric condition (125 V/cm, 4 pulses x 2 times, 50 ms, 1 Hz). Exact salt concentrations of DNA vehicle were measured by the inductively coupled plasma-atomic emission spectrometer (ICP-AES) and the conductivity change in the tissue induced by the salt in the medium was measured by Low-Frequency (LF) Impedance Analyzer. Luciferase expression in-creased as cation concentration of vehicle dec-reased and this result can be visualized by X-Gal staining. However, at lower salt concentration, transfection efficiency was diminished because the hypoosmotic stress and electrical injury by low conductivity induced myofiber damage. At optimal salt concentration (71 mM), we observed a 3-fold average increase in luciferase expression in comparison with the normal saline condition (p < 0.01). These results provide a valuable experimental parameter for in vivo gene therapy mediated by electroporation.
Animals
;
Comparative Study
;
DNA/*administration & dosage/metabolism
;
Drug Delivery Systems
;
Electric Conductivity
;
Electroporation/methods
;
Escherichia coli/genetics
;
Female
;
Gene Therapy/*methods
;
*Gene Transfer Techniques
;
Genes, Reporter
;
Injections, Intramuscular
;
Luciferase/metabolism
;
Mice
;
Mice, Inbred BALB C
;
Muscle, Skeletal/drug effects/*metabolism/pathology
;
Osmolar Concentration
;
Plasmids/genetics/*metabolism
;
Sodium Chloride/*pharmacology
;
Transfection
;
Vehicles/*administration & dosage
;
beta-Galactosidase/metabolism
4.Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation.
Min Jae LEE ; Soon Shin CHO ; Hyung Suk JANG ; Young Shin LIM ; Ji Ran YOU ; Jang Won PARK ; Hea Ran SUH ; Jeong A KIM ; Jong Sang PARK ; Duk Kyung KIM
Experimental & Molecular Medicine 2002;34(4):265-272
In vivo electroporation has emerged as a leading technology for developing nonviral gene therapies, and the various technical parameters governing electroporation efficiency have been optimized by both theoretical and experimental analysis. However, most electroporation parameters focused on the electric conditions and the preferred vehicle for plasmid DNA injections has been normal saline. We hypothesized that salts in vehicle for plasmid DNA must affect the efficiency of DNA transfer because cations would alter ionic atmosphere, ionic strength, and conductivity of their medium. Here, we show that half saline (71 mM) is an optimal vehicle for in vivo electroporation of naked DNA in skeletal muscle. With various salt concentrations, two reporter genes, luciferase and beta-galactosidase were injected intramuscularly under our optimal electric condition (125 V/cm, 4 pulses x 2 times, 50 ms, 1 Hz). Exact salt concentrations of DNA vehicle were measured by the inductively coupled plasma-atomic emission spectrometer (ICP-AES) and the conductivity change in the tissue induced by the salt in the medium was measured by Low-Frequency (LF) Impedance Analyzer. Luciferase expression in-creased as cation concentration of vehicle dec-reased and this result can be visualized by X-Gal staining. However, at lower salt concentration, transfection efficiency was diminished because the hypoosmotic stress and electrical injury by low conductivity induced myofiber damage. At optimal salt concentration (71 mM), we observed a 3-fold average increase in luciferase expression in comparison with the normal saline condition (p < 0.01). These results provide a valuable experimental parameter for in vivo gene therapy mediated by electroporation.
Animals
;
Comparative Study
;
DNA/*administration & dosage/metabolism
;
Drug Delivery Systems
;
Electric Conductivity
;
Electroporation/methods
;
Escherichia coli/genetics
;
Female
;
Gene Therapy/*methods
;
*Gene Transfer Techniques
;
Genes, Reporter
;
Injections, Intramuscular
;
Luciferase/metabolism
;
Mice
;
Mice, Inbred BALB C
;
Muscle, Skeletal/drug effects/*metabolism/pathology
;
Osmolar Concentration
;
Plasmids/genetics/*metabolism
;
Sodium Chloride/*pharmacology
;
Transfection
;
Vehicles/*administration & dosage
;
beta-Galactosidase/metabolism
5.Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection.
Ji Hun KIM ; Jeong Won JANG ; Chan Ran YOU ; Si Young YOU ; Mun Kyung JUNG ; Jin Hwan JUNG
Gut and Liver 2009;3(3):218-221
It is known that neutropenia caused by combination pegylated interferon plus ribavirin therapy for hepatitis C virus (HCV) infection is well tolerated and carries a negligible risk of infection. Neutropenic enterocolitis is encountered most frequently in patients with hemato-oncologic diseases who are undergoing intensive chemotherapy. However, little information exists regarding this life-threatening event in the setting of HCV therapy. We present here an unusual case of fatal neutropenic enterocolitis in a cirrhotic patient receiving combination therapy for HCV infection. This is the first report of a death from neutropenic enterocolitis associated with treatment for chronic HCV infection. The present case suggests that caution should be exercised when continuing HCV therapy in neutropenic patients with advanced fibrosis, and the decision to maintain such therapy should be balanced against the potential for serious adverse events.
Enterocolitis, Neutropenic
;
Fibrosis
;
Hepacivirus
;
Hepatitis C
;
Hepatitis C, Chronic
;
Hepatitis, Chronic
;
Humans
;
Interferons
;
Neutropenia
;
Ribavirin
6.Diagnosis and treatment of vasoactive intestinal peptide-secreting-tumors: one case report and 15 years review in China.
Jiang-tao LI ; Shu-you PENG ; Ying-bin LIU ; He-qing FANG ; Yu-lian WU ; Xin-bao WANG ; Zhe TANG ; Hao-ran QIAN ; Cheng JI
Chinese Journal of Surgery 2004;42(9):524-527
OBJECTIVETo discuss the experiences of diagnosis and treatment for vasoactive intestinal peptide-secreting-tumors (VIPoma) by summarizing clinical informations of 15 patients with VIPoma.
METHODSTo analyze Clinical manifestations, laboratory examinations, imaging features, operation, pathological findings and follow up survey of 15 patients, among them 1 case from our hospital and the other 14 cases were searched in chinese biological and medical literature database from Jan 1987 to Dec 2002.
RESULTSThe main clinical manifestation include periodical secretory watery diarrhea, hypokalemia, achlorhydria, in addition, periodical backache, skin rash, and polyps of colon were presented in the case in our hospital. The immunohistochemical expression of many kinds of digestive hormone including VIP presented positive; All clinical symptoms of which except polyps disappeared after operation, elevated VIP data in serum also markedly decreased. Part resection of superior mesenteric vein was performed in the same patient.
CONCLUSIONSVIPoma is rare. Typical symptoms and the serum value of VIP were keys to diagnosis, the operation is the most effective means for treatment. Resection of tumor, Radiofrequency tissue ablation, liver transplantation can be selected for metastatic VIPoma in the liver.
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Pancreatic Neoplasms ; diagnosis ; pathology ; therapy ; Vasoactive Intestinal Peptide ; secretion ; Vipoma ; diagnosis ; pathology ; therapy
7.Upper Gastrointestinal Hemorrhage from Pancreatic Pseudocyst Involving the Duodenum: A Case Report.
Chan Ran YOU ; Seung Whan SHIN ; Bo In LEE ; Jeong Seon JI ; Byung Wook KIM ; Hwang CHOI ; Se Hyun CHO ; Hiun Suk CHAE ; Kyu Yong CHOI ; In Sik CHUNG
Korean Journal of Gastrointestinal Endoscopy 2004;29(4):217-221
Most pancreatic pseudocysts are located in or around the pancreas, but they can be found in all the potential spaces around viscera in and outside of the abdominal cavity. The complications of pancreatic pseudocysts are infection, rupture, fistula, obstruction and hemorrhage. However, an upper gastrointestinal bleeding caused by pancreatic pseudocyst is rare. Pseudocysts with complication like hemorrhage require percutaneous, endoscopic or surgical treatment. We report a case of the pancreatic pseudocyst involving duodenal wall with upper gastrointestinal hemorrhage, which was improved by conservative treatment.
Abdominal Cavity
;
Duodenum*
;
Fistula
;
Gastrointestinal Hemorrhage*
;
Hemorrhage
;
Pancreas
;
Pancreatic Pseudocyst*
;
Rupture
;
Viscera
8.Acute Gouty Arthritis Presented after Pyrazinamide Treatment in a Patient with Chronic Renal Insufficiency.
Ki Hoon HUR ; Sun Ae YOON ; Young Ok KIM ; Kang Woo LEE ; Ji Hyun JUNG ; Chan Ran YOU ; Sun Wha SONG ; Kyung Soo PARK ; Kwan Hyung KIM
Korean Journal of Nephrology 2003;22(5):586-589
Although arthralgia with or without hyperuricemia commonly occurs in a patient receiving antituberculous treatment including pyrazinamide, acute gouty arthritis is rarely reported. Here we report a case of acute gouty arthritis presented after antituberculous treatment in a patient with asymptomatic hyperuricemia and mild renal insufficiency. A 76-year-old woman complained sudden onset of painful swelling in both first metatarsophalangeal joints 9 weeks after antituberculous treatment. She had hypertensive nephropathy with mild renal insufficiency and asymptomatic hyperuricemia for 8 years. Needle aspiration of the joint fluid demonstrated needle-shaped strongly negative birefringent monosodium urate crystal. The painful swelling improved with steroid and colchicine.
Aged
;
Arthralgia
;
Arthritis, Gouty*
;
Colchicine
;
Female
;
Humans
;
Hyperuricemia
;
Joints
;
Metatarsophalangeal Joint
;
Needles
;
Pyrazinamide*
;
Renal Insufficiency
;
Renal Insufficiency, Chronic*
;
Tuberculosis
;
Uric Acid
9.An open, Multi center, Randomized, Parallel Group Study to Compare the Effectiveness and Safety of Fluticasone Plus Tulobuterol Versus Twice the Dose of Fluticasone Alone in Asthmatic Children .
You Hoon JEON ; Hyeon Jong YANG ; Young YOO ; Young Ho KIM ; Ji Tae JEONG ; Hae Ran LEE ; Bok Yang PYUN
Pediatric Allergy and Respiratory Disease 2009;19(2):125-136
PURPOSE: We aim to compare the effectiveness and safety of fluticasone propionate (Flt) plus tulobuterol (Hk) versus high-dose Flt alone in controlling asthma in children. METHODS: Fifty three children aged 4 to 8 years, who were diagnosed with mild persistent asthma and underwent maintenance therapy with a low dose of inhaled corticosteroid (Flt) of 50-100 microgram/day were randomized to receive Flt plus Hk (Hokunalin(R) patch 1 mg, Abbott Japan, Tokyo, Japan), or Flt alone at twice the dosage. Patients underwent new treatment for 4 weeks. Asthma symptom scores, mean changes in morning and evening peak expiratory flow (PEF), the frequency of night awakenings, the use of reliever medication, caregiver's overall satisfaction and safety were evaluated and compared in each group. And they were followed-up again 4 week after treatment course for the evaluation of treatment-emergent adverse event (TEAE). RESULTS: No significant difference was found between the groups in terms of mean changes in the morning and evening PEF, the frequency of night awakening, the use of rescue medication and caregiver's overall satisfaction (P=0.83, P=0.83, P=0.17, P=0.32 and P=0.63). Furthermore, no statistically significant difference was observed between 2 groups in the incidence of any TEAE (P=1.00). CONCLUSION: This study demonstrated that a combination of Flt and Hk was as effective as a high-dose Flt therapy in the management of mild persistent asthma in children. The results of this study suggest that tulobuterol add-on therapy can be considered as a reasonable substitute to an increase in the dosage of steroid in the patients with steroid-phobia and it might be used to reduce the risk of high dose steroid therapy.
Aged
;
Androstadienes
;
Asthma
;
Child
;
Diethylpropion
;
Humans
;
Incidence
;
Japan
;
Terbutaline
;
Tokyo
;
Fluticasone
10.Garlic powder intake and cardiovascular risk factors: a meta-analysis of randomized controlled clinical trials.
Jin Sook KWAK ; Ji Yeon KIM ; Ju Eun PAEK ; You Jin LEE ; Haeng Ran KIM ; Dong Sik PARK ; Oran KWON
Nutrition Research and Practice 2014;8(6):644-654
BACKGROUND/OBJECTIVES: Although preclinical studies suggest that garlic has potential preventive effects on cardiovascular disease (CVD) risk factors, clinical trials and reports from systematic reviews or meta-analyses present inconsistent results. The contradiction might be attributed to variations in the manufacturing process that can markedly influence the composition of garlic products. To investigate this issue further, we performed a meta-analysis of the effects of garlic powder on CVD risk factors. MATERIALS/METHODS: We searched PubMed, Cochrane, Science Direct and EMBASE through May 2014. A random-effects meta-analysis was performed on 22 trials reporting total cholesterol (TC), 17 trials reporting LDL cholesterol (LDL-C), 18 trials reporting HDL cholesterol (HDL-C), 4 trials reporting fasting blood glucose (FBG), 9 trials reporting systolic blood pressure (SBP) and 10 trials reporting diastolic blood pressure (DBP). RESULTS: The overall garlic powder intake significantly reduced blood TC and LDL-C by -0.41 mmol/L (95% confidence interval [CI], -0.69, -0.12) (-15.83 mg/dL [95% CI, -26.64, -4.63]) and -0.21 mmol/L (95% CI, -0.40, -0.03) (-8.11 mg/dL [95% CI, -15.44, -1.16]), respectively. The mean difference in the reduction of FBG levels was -0.96 mmol/L (95% CI, -1.91, -0.01) (-17.30 mg/dL [95% CI, -34.41, -0.18]). Evidence for SBP and DBP reduction in the garlic supplementation group was also demonstrated by decreases of -4.34 mmHg (95% CI, -8.38, -0.29) and -2.36 mmHg (95% CI, -4.56, -0.15), respectively. CONCLUSIONS: This meta-analysis provides consistent evidence that garlic powder intake reduces the CVD risk factors of TC, LDL-C, FBG and BP.
Blood Glucose
;
Blood Pressure
;
Cardiovascular Diseases
;
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Fasting
;
Garlic*
;
Risk Factors*